ST
PTCT icon

Spot Trading’s PTC Therapeutics PTCT Stock Holding History

Spot Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.87M Buy
193,200
+188,300
+3,843% +$3.69M 0.07% 389
2017
Q2 		$90K Sell
4,900
-5,600
-53% -$75.5K ﹤0.01% 2636
2017
Q1 		$103K Buy
+10,500
New +$127K ﹤0.01% 2245
2016
Q1 		– Sell
-600
Closed -$19K – 3857
2015
Q4 		$19K Sell
600
-5,900
-91% -$174K ﹤0.01% 3236
2015
Q3 		$174K Buy
6,500
+6,200
+2,067% +$265K ﹤0.01% 2774
2015
Q2 		$14K Sell
300
-15,300
-98% -$893K ﹤0.01% 3516
2015
Q1 		$949K Buy
+15,600
New +$952K 0.01% 1645

Other funds holding PTCT

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Spot Trading's PTCT Position: Q3 2017 in Review

Spot Trading increased its PTC Therapeutics (PTCT) stake by 283% in Q3 2017, buying an estimated $376K and bringing the position to 26,006 shares worth $520K. The position accounts for 0.01% of the portfolio, ranked #1618.

Spot Trading first reported a position in PTCT in Q1 2015 and has held it in 4 quarters since. 129 funds tracked by Wall St. Rank hold PTCT as of Q3 2017.

  • Spot Trading held 26,006 shares of PTC Therapeutics worth $520K as of Q3 2017.
  • Spot Trading bought 19,221 PTC Therapeutics shares in Q3 2017, an estimated $376K.
  • PTC Therapeutics made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1618 holding.
  • Spot Trading first reported a position in PTC Therapeutics in Q1 2015 and has held it in 4 quarters since.
  • 129 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.